Cutler K, Kagen M H, Don P C, McAleer P, Weinberg J M
Department of Dermatology, New York Medical College-Metropolitan Hospital Center, NY, USA.
Acta Derm Venereol. 2000 Mar-Apr;80(2):134-5.
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.
咪喹莫特是一种最近研发的咪唑喹啉杂环胺,属于免疫反应调节剂。外用5%咪喹莫特乳膏治疗免疫功能正常个体的尖锐湿疣已显示出有前景的结果。我们在此报告首例外用5%咪喹莫特乳膏成功治疗一名感染人类免疫缺陷病毒个体面部疣的病例。